Lonza Group Taps Pearl Huang for Independent Board Seat

• Lonza has nominated Pearl Huang as an independent member of its Board of Directors, subject to election at the May 2027 AGM.
• If elected, Huang will join the Strategy and Innovation Committee and the Remuneration Committee.
• Huang brings pharmaceutical and biotech leadership and scientific expertise; she has held senior roles at Roche, GSK and Merck, and co-founded BeiGene.
• Huang currently serves as an independent director of Waters Corporation and BB Biotech and holds a PhD from Princeton and a biology degree from MIT.
• Angelica Kohlmann and Christoph Mäder will not seek re-election at the 2027 AGM after long-standing Board service.
• Since 2024, Lonza’s Board has gained eight new members, strengthening its industry expertise, strategic capabilities and international experience.

The next important date, "Quartalsmitteilung" — "quarterly report" (also: "quarterly statement" or "quarterly announcement," depending on context)., at Lonza Group is on 27.01.2027.

The price of Lonza Group at the time of the news was 623,10EUR and was up +0,48 % compared with the previous day.
15 minutes after the article was published, the price was 620,90EUR this corresponds to a minus of -0,35 % since publication.

Lonza Group

+1,30 %

-0,38 %

+3,07 %

-1,27 %

+4,09 %

+39,54 %

-4,00 %

+300,53 %

+971,42 %

ISIN:CH0013841017WKN:928619

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max

Lonza Group direkt bei SMARTBROKER+ handelnKaufVerkauf

Prämie Jetzt bis zu 120 € Prämie sichern! Egal ob Trading, Sparen oder beides - bei SMARTBROKER+ ist für alle was dabei. Jetzt Depot eröffnen und sichern!

Schreibe Deinen Kommentar